Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about CYBN
Recent news which mentions CYBN
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Cybin Developing Safer, More Effective Psilocybin Therapies
December 14, 2021
Tickers
CYBN
Tags
Market News
InvestorBrandNetwork
Biotech
From
Benzinga
Cybin to Fund, Support Psychedelic Clinic at Manhattan Hospital
December 10, 2021
Tickers
CYBN
Tags
Benzinga
Partner Content
Penny Stocks
From
Benzinga
Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
December 09, 2021
Tickers
ATAI
CYBN
MNMD
Tags
Penny Stocks
MNMD
News
From
Benzinga
Cybin Touts Highlights of 'Transformative' Second-Quarter Performance
December 02, 2021
Tickers
CYBN
Tags
News
Penny Stocks
Health Care
From
Benzinga
Cybin Announces FDA Approvals, Participation in Conference
December 01, 2021
Tickers
CYBN
Tags
Regulations
CYBN
Market News
From
Benzinga
Psilocybin Trials For COVID-Related Distress Of Healthcare Professionals Could Validate New Psychotherapy Model
November 30, 2021
Tickers
CYBN
Tags
CYBN
Cannabis
Markets
From
Benzinga
Cybin To Test Psychedelic-Assisted Psychotherapy For COVID-Related Distress
November 30, 2021
Tickers
CYBN
Tags
Phase 2 Trial
Biotech
General
From
Benzinga
Cybin Supports Psychedelic Treatment Clinic Through Grant
November 23, 2021
Tickers
CYBN
Tags
Market News
InvestorBrandNetwork
CYBN
From
Benzinga
NY's Lenox Hill Hospital With Cybin-Awarded Grant Will Provide Psychedelic Therapy To City's Underserved
November 23, 2021
Tickers
CYBN
Tags
MDMA
General
Benzinga
From
Benzinga
Cybin 'One Step Closer' to Creating Best Therapy for Mental Health
November 19, 2021
Tickers
CYBN
Tags
Benzinga
Partner Content
Health Care
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
Tickers
ABCL
ACGL
AIG
AJG
Tags
HIG
REPL
SAIA
From
Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Tickers
CYBN
Tags
Market News
Doug Drysdale
Earnings
From
Benzinga
Cybin Releases Q2 Financial Results
November 15, 2021
Tickers
CYBN
Tags
General
Benzinga
Partner Content
From
Benzinga
Can The Psychedelics Boom Go Bust? A Conversation With Cybin Chief Clinical Officer Dr. Alex Belser
November 14, 2021
Tickers
CYBN
Tags
Small Cap
CYBN
psychedelics
From
Benzinga
Cybin Unveils Data Suggesting Its Novel Psilocybin Analog Is the 'Superior Molecule'
November 11, 2021
Tickers
CYBN
Tags
Benzinga
contributors
Penny Stocks
From
Benzinga
Cybin CEO Presenting at Jefferies London Healthcare Conference
November 11, 2021
Tickers
CYBN
Tags
Partner Content
Benzinga
Health Care
From
Benzinga
Cybin to Release Q2 2021 Results on November 15
November 09, 2021
Tickers
CYBN
Tags
CYBN
Small Cap
Market News
From
Benzinga
32 Stocks Moving in Tuesday's Pre-Market Session
November 09, 2021
Tickers
AMRS
APRN
ARVL
ATER
Tags
DVD
PVG
KIND
From
Benzinga
64 Biggest Movers From Yesterday
November 09, 2021
Tickers
ALHC
ALIM
ASRT
AURA
Tags
OTRK
DTEA
IHT
From
Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
November 08, 2021
Tickers
CYBN
Tags
News
Penny Stocks
Psychedelics Therapy
From
Benzinga
Cybin's CYB003 Demonstrates Advantages over Oral Psilocybin for Mental Health
November 08, 2021
Tickers
CYBN
Tags
General
Penny Stocks
Health Care
From
Benzinga
Why Cybin Stock Is Down on Monday
November 08, 2021
Tickers
CYBN
Tags
CYBN
Recent Press Releases
Market News
From
Motley Fool
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
Tickers
CMPS
CYBN
FLHLF
NMLSF
Tags
Benzinga
NMLSF
FLHLF
From
Benzinga
Cybin Gets DEA License To Work With Scheduled Psychedelic Molecules
November 04, 2021
Tickers
CYBN
DEA
Tags
Small Cap
CYBN
psychedelics
From
Benzinga
Cybin Inc. Receives Schedule I Manufacturing License from DEA
November 04, 2021
Tickers
CYBN
Tags
Penny Stocks
Health Care
Cannabis
From
Benzinga
Cybin Inc. Schedules R&D Briefing to Release Breakthrough Research Findings
November 02, 2021
Tickers
CYBN
Tags
Penny Stocks
Benzinga
Partner Content
From
Benzinga
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation
November 01, 2021
Tickers
AWKNF
CYBN
DELCF
MCURF
Tags
MCURF
Benzinga
AWKNF
From
Benzinga
Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex
October 27, 2021
Tickers
CYBN
Tags
General
Cybin
Benzinga
From
Benzinga
Cybin Inc. Announces FDA IND Authorization of Potentially Pivotal Study
October 27, 2021
Tickers
CYBN
Tags
Health Care
Partner Content
Benzinga
From
Benzinga
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent
October 26, 2021
Tickers
AWKNF
CMPS
CYBN
DMTTF
Tags
Penny Stocks
Small Cap
CYBN
From
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.